Home » Topics » Conferences

Conferences
RSS

SB team attempts to identify the source of antiparkinsonian activity of SKF-83959

Nov. 13, 1998

New cytokine modulator from Schering-Plough is active in models of endotoxemia

Nov. 13, 1998

Renal protective effect of efonidipine in hypertensive patients

Nov. 13, 1998

OPC-21268 improves glomerulonephritis in hypercholesterolemic rats, nephropathy in diabetic rats

Nov. 13, 1998

Serum complement activation is implicated in the pathogenesis of CHF

Nov. 13, 1998

Vasopressin V2 receptor antagonist beneficial in mouse model of PKD

Nov. 13, 1998

VPA-985 characterized as potent, selective, orally active V2 antagonist

Nov. 13, 1998

BG-9719 has potent natriuretic effects in patients with CHF

Nov. 13, 1998

McMaster University researchers target potential gene therapies for arthritis

Nov. 13, 1998

Bristol-Myers Squibb initiates phase III HBV clinical trials; phase II data reported

Nov. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...